🔗 Share this article

Treasury head Rachel Reeves has stated she is preparing "specific action to deal with household expense issues" in next month's financial statement.

Speaking to media outlets, she noted that lowering price rises is a shared duty of both the administration and the Bank of England.

The United Kingdom's price growth is projected to be the most elevated among the G7 developed nations this year and the following year.

Potential Energy Cost Measures

Reports indicate the government could take action to bring down utility costs, for instance by cutting the current 5% level of VAT charged on energy supplies.

A further approach is to cut some of the policy costs currently added to bills.

Fiscal Constraints and Expert Predictions

The government will receive the next assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will reveal how much scope there is for such actions.

The view from the majority of economists is that Reeves will have to announce tax rises or expenditure reductions in order to meet her voluntary fiscal targets.

Previously on the same day, estimates showed there was a twenty-two billion pound deficit for the chancellor to fill, which is at the lower end of forecasts.

"It is a joint task between the Bank of England and the administration to further reduce some of the drivers of inflation," the Chancellor stated to reporters in the US capital, at the annual meetings of the IMF and global financial institution.

Tax Pledges and Global Concerns

While a great deal of the attention has been on probable tax increases, the Treasury chief said the latest data from the OBR had not altered her vow to manifesto promises not to increase rates on income tax, sales tax or social security contributions.

She blamed an "uncertain world" with increasing geopolitical and commercial tensions for the fiscal revenue measures, probably to be directed on those "wealthiest."

International Economic Disputes

Addressing apprehensions about the UK's economic relations with the Asian nation she said: "Our security interests always are paramount."

Last week's announcement by Chinese authorities to increase trade restrictions on critical minerals and other resources that are key for high-technology manufacturing led US President Donald Trump to propose an further 100% import tax on goods from the Asian country, increasing the prospect of an full-scale trade war between the two largest economies.

The American finance chief described the Chinese action "commercial pressure" and "a global supply chain power grab."

Inquired about considering the American proposal to join its conflict with the Asian nation, the Chancellor said she was "deeply worried" by China's measures and urged the Beijing authorities "not to put up barriers and restrict access."

She said the decision was "damaging for the international commerce and causes additional headwinds."

"It is my opinion there are fields where we should confront China, but there are also important opportunities to trade with China's economy, including financial services and other sectors of the economy. We've got to get that equilibrium correct."

The chancellor also affirmed she was collaborating with other major economies "regarding our own essential resources plan, so that we are more independent."

Health Service Drug Pricing and Funding

Reeves also acknowledged that the cost the NHS spends on medicines could increase as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in return for lower tariffs and investment.

A number of the world's largest pharmaceutical manufacturers have said recently that they are either pausing or abandoning operations in the United Kingdom, with some attributing the insufficient payments they are getting.

Recently, the Science Minister said the cost the NHS spends on drugs would need to increase to stop businesses and pharmaceutical investment departing from the UK.

The Chancellor told media: "It has been observed as a result of the pricing regime, that clinical trials, new drugs have not been provided in the United Kingdom in the manner that they are in other continental states."

"Our aim is to guarantee that individuals receiving care from the NHS are able to receive the top life-saving medicines in the world. And so we are looking at all of that, and... seeking to attract increased capital into the UK."